Phase II study of nivolumab in patients with genetic alterations in DNA damage repair and response who progressed after standard treatment for metastatic solid cancers (KM-06)
- Ju Won Kim
- , Hyo Jin Lee
- , Ji Yoon Lee
- , Sook Ryun Park
- , Yu Jung Kim
- , In Gyu Hwang
- , Woo Kyun Bae
- , Jae Ho Byun
- , Jung Sun Kim
- , Eun Joo Kang
- , Jeeyun Lee
- , Sang Joon Shin
- , Won Jin Chang
- , Eun Ok Kim
- , Jason K. Sa
- , Kyong Hwa Park*
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
6
Link opens in a new tab
Citations
(Scopus)